|
|
||||||||
The Journal of Immunology, Vol 147, Issue 8 2586-2594, Copyright © 1991 by American Association of Immunologists
ARTICLES |
HE Broxmeyer, B Sherry, S Cooper, FW Ruscetti, DE Williams, P Arosio, BS Kwon and A Cerami
Department of Medicine (Hematology/Oncology), Indiana University School of Medicine, Indianapolis 46202.
The effects of recombinant murine macrophage inflammatory protein (MIP)- 1 beta and MIP-2 on the suppressive activity of MIP-1 alpha were tested using colony formation by human and murine bone marrow burst-forming unit-erythroid (BFU-E), colony-forming unit-granulocyte erythroid macrophage, megakaryocyte (CFU-GEMM), and colony-forming unit- granulocyte macrophage (CFU-GM) progenitor cells. MIP-1 beta, but not MIP-2, when added with MIP-1 alpha to cells, blocked the suppressive effects of MIP-1 alpha on both human and murine BFU-E, CFU-GEMM, and CFU-GM colony formation. Similar results were observed regardless of the early acting cytokines used: human rGM-CSF plus human rIL-3, and two recently described potent cytokines, a genetically engineered human rGM-CSF/IL-3 fusion protein and MGF, a c-kit ligand. The more potent the stimuli, the greater the suppressive activity noted. Pulse treatment of hu bone marrow cells with MIP-1 alpha at 4 degrees C for 1 h was as effective in inhibiting colony formation as continuous exposure of cells to MIP-1 alpha, and the pulsing effect with MIP-1 alpha could not be overcome by subsequent exposure of cells to MIP-1 beta. Also, pulse exposure of cells to MIP-1 beta blocked the activity of subsequently added MIP-1 alpha. For specificity, the action of a nonrelated myelosuppressive factor H-ferritin, was compared. MIP-1 alpha and H-ferritin were shown to act on similar target populations of early BFU-E, CFU-GEMM, and CFU-GM. MIP-1 beta did not block the suppressive activity of H-ferritin. Also, hemin and an inactive recombinant human H-ferritin mutein counteracted the suppressive effects of the wildtype H-ferritin molecule, but did not block the suppressive effects of MIP-1 alpha. These results show that MIP-1 beta's ability to block the action of MIP-1 alpha is specific. In addition, the results suggest that MIP-1 alpha and MIP-beta can, through rapid action, modulate early myeloid progenitor cell proliferation.
This article has been cited by other articles:
![]() |
M. Jaramillo and M. Olivier Hydrogen Peroxide Induces Murine Macrophage Chemokine Gene Transcription Via Extracellular Signal-Regulated Kinase- and Cyclic Adenosine 5'-Monophosphate (cAMP)-Dependent Pathways: Involvement of NF-{kappa}B, Activator Protein 1, and cAMP Response Element Binding Protein J. Immunol., December 15, 2002; 169(12): 7026 - 7038. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Lindell, T. J. Standiford, P. Mancuso, Z. J. Leshen, and G. B. Huffnagle Macrophage Inflammatory Protein 1{alpha}/CCL3 Is Required for Clearance of an Acute Klebsiella pneumoniae Pulmonary Infection Infect. Immun., October 1, 2001; 69(10): 6364 - 6369. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Martiney, B. Sherry, C. N. Metz, M. Espinoza, A. S. Ferrer, T. Calandra, H. E. Broxmeyer, and R. Bucala Macrophage Migration Inhibitory Factor Release by Macrophages after Ingestion of Plasmodium chabaudi-Infected Erythrocytes: Possible Role in the Pathogenesis of Malarial Anemia Infect. Immun., April 1, 2000; 68(4): 2259 - 2267. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.D. Cashman, I. Clark-Lewis, A.C. Eaves, and C.J. Eaves Differentiation Stage-Specific Regulation of Primitive Human Hematopoietic Progenitor Cycling by Exogenous and Endogenous Inhibitors in an In Vivo Model Blood, December 1, 1999; 94(11): 3722 - 3729. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Imai, T. Yoshida, M. Baba, M. Nishimura, M. Kakizaki, and O. Yoshie Molecular Cloning of a Novel T Cell-directed CC Chemokine Expressed in Thymus by Signal Sequence Trap Using Epstein-Barr Virus Vector J. Biol. Chem., August 30, 1996; 271(35): 21514 - 21521. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Veiby, S LoCastro, P Bhatnagar, and W. Olsen Inhibition of enriched stem cells in vivo and in vitro by the hemoregulatory peptide SK&F108636 Stem Cells, March 1, 1996; 14(2): 215 - 224. [Abstract] |
||||
![]() |
T. J. Daly, G. J. LaRosa, S. Dolich, T. E. Maione, S. Cooper, and H. E. Broxmeyer High Activity Suppression of Myeloid Progenitor Proliferation by Chimeric Mutants of Interleukin 8 and Platelet Factor 4 J. Biol. Chem., October 6, 1995; 270(40): 23282 - 23292. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Aronica, C. Mantel, R. Gonin, M. S. Marshall, A. Sarris, S. Cooper, N. Hague, X.-f. Zhang, and H. E. Broxmeyer Interferon-inducible Protein 10 and Macrophage Inflammatory Protein-1alpha Inhibit Growth Factor Stimulation of Raf-1 Kinase Activity and Protein Synthesis in a Human Growth Factor-dependent Hematopoietic Cell Line J. Biol. Chem., September 15, 1995; 270(37): 21998 - 22007. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |